Empowering Europe’s Public Sector: Learning Tree Partners with Abilways to Deliver Advanced Training for the European Commission via framework service contract number EC-HR/2024/OP/0013 – Lot 2

LONDON, Feb. 11, 2026 (GLOBE NEWSWIRE) — A shared commitment to strengthening Europe’s public sector workforce has united Learning Tree International and Abilways in delivering advanced training solutions for the European Commission (EC) and its affiliated entities. Under framework service contract number EC-HR/2024/OP/0013 – Lot 2, Learning Tree will design

Read More

Terrestar Launches Canada-Wide Hybrid Satellite IoT Service Powered by Mavenir’s Cloud-Native Virtualized RAN and Core

Commercial launch marks a milestone for 3GPP standards-based Non-Terrestrial Network (NTN) services MONTRÉAL, Feb. 11, 2026 (GLOBE NEWSWIRE) — Terrestar Solutions Inc., Canada’s only domestically headquartered and controlled mobile satellite service operator, and Mavenir the software company building AI-by-design mobile networks, today announce the commercial launch of Terrestar’s Hybrid Satellite

Read More

آئی ایل ایس ٹی سی کے لیے بین الاقوامی تبادلہ و تعاون کا رابطہ جاتی نظام قائم

دفترِ خارجہ، چونگ چنگ میونسپل حکومت چونگ چنگ، چین، 11 فروری 2026 /شنہوا-ایشیانیٹ/—نئی بین الاقوامی لینڈ-سی ٹریڈ کوریڈور (آئی ایل ایس ٹی سی) کے لیے بین الاقوامی تبادلہ و تعاون کا رابطہ جاتی نظام 10 فروری کو چونگ چنگ میں باضابطہ طور پر افتتاح کر دیا گیا، جس کا مقصد

Read More

AlphaTON Capital at Consensus Hong Kong: Unveiling the Confidential AI Infrastructure for 1 Billion Users

CEO Brittany Kaiser, Strategic Advisor Anthony Scaramucci, and Midnight Foundation President Fahmi Syed to Showcase AlphaTON’s First-Mover Position in Privacy-Preserving AI at Scale HONG KONG, Feb. 10, 2026 (GLOBE NEWSWIRE) — AlphaTON Capital Corp. (Nasdaq: ATON), the world’s leading public technology company scaling the Telegram super app for an addressable

Read More

Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution

Former President of Shire PLC’s (“Shire”) Specialty Pharmaceutical business, with more than 30 years of experience across neuroscience, rare disease, and specialty pharmaceuticals, including senior leadership roles at Astra-Merck and AstraZeneca PLC Proven leader in late-stage clinical development, global commercialization, and capital formation across central nervous system (“CNS”) programs Appointed

Read More